LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM

Manufacturer
GTG Wellness Co., Ltd. | YUYU LnP Inc
Effective date
2023-02-24
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:54:16

Label at a glance#

ProductLEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM
Active ingredientNiacinamide
Label structure8 sections

Indications and uses

■ It makes improvement in skin tone evenness and level of brightness.

Dosage and administration

■ Apply the LEBODY LAB RENEWAL DUAL EFFECT SERUM to the back of your hand with the included applicator, then apply it to the area you want to use and rub lightly.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 2%

Adenosine 0.04%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, Butylene Glycol, Glycereth-26, Salicornia Herbacea Extract, Phragmites Communis Extract, Dipropylene Glycol, Ammonium Acryloyldimethyltaurate/VP Copolymer, Hydroxyacetophenone, Glycerin, Cellulose Gum, PEG-40 Hydrogenated Castor Oil, Caprylyl Glycol, Xanthan Gum, 1,2-Hexanediol, Hydrogenated Lecithin, Caprylic/Capric Triglyceride, Disodium EDTA, Panthenol, Hydroxydecyl Ubiquinone, Glycine Soja (Soybean) Sterols, Sodium Hyaluronate, Dipotassium Glycyrrhizate, Honey Extract, Beta-Glucan

PURPOSE

OTC - PURPOSE SECTION

Skin Brightening

Anti wrinkle

Cautions

WARNINGS SECTION

1. In case of using cosmetics or after use, please consult a specialist if there is any abnormal symptom or side effect such as red spot, swelling or itching in direct sunlight.
2. Do not use on wounded areas.
3. Precautions for storage and handling
a) Keep out of reach of children.
b) Avoid direct sunlight.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ It makes improvement in skin tone evenness and level of brightness.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Apply the LEBODY LAB RENEWAL DUAL EFFECT SERUM to the back of your hand with the included applicator, then apply it to the area you want to use and rub lightly.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71080-0008-1LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM30 mL in 1 CONTAINERLIQUID302
71080-0008-2LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM1 in 1 CARTONLIQUID12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71080-0008LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM (NIACINAMIDE, ADENOSINE) LIQUID [GTG WELLNESS CO., LTD.]2Legacy NDC, 2 package rows20230225_93e4b82b-63da-465e-b66d-e825aaf7e747.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71080-000871080-0008-1, 71080-0008-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Niacinamide25X51I8RD4ACTIB
Water059QF0KO0RIACT
Propanediol5965N8W85TIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ee29d0ad-5047-49af-b2b9-4a523671ac2293e4b82b-63da-465e-b66d-e825aaf7e7472023-02-24WarningsExact identifier
spl id: ee29d0ad-5047-49af-b2b9-4a523671ac22
spl set id: 93e4b82b-63da-465e-b66d-e825aaf7e747

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.